Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

Polypharmacy in patients with advanced cancer and pain: a European cross-sectional study of 2282 patients.

Kotlinska-Lemieszek A, Paulsen O, Kaasa S, Klepstad P.

J Pain Symptom Manage. 2014 Dec;48(6):1145-59. doi: 10.1016/j.jpainsymman.2014.03.008. Epub 2014 Apr 26.

PMID:
24780183
2.

Quantifying the impact of drug-drug interactions associated with opioids.

Pergolizzi JV.

Am J Manag Care. 2011 Sep;17 Suppl 11:S288-92.

3.

Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States.

Rasu RS, Vouthy K, Crowl AN, Stegeman AE, Fikru B, Bawa WA, Knell ME.

J Manag Care Spec Pharm. 2014 Sep;20(9):921-8.

4.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
5.

How frequently are contraindicated or warned against combinations of drugs prescribed to patients receiving long-term opioid therapy for chronic pain?

Richarz U, Jacobs A, Spina E.

Pharmacoepidemiol Drug Saf. 2012 May;21(5):453-62. doi: 10.1002/pds.2250. Epub 2011 Nov 14.

PMID:
22081534
6.

Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study.

Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA.

Pain. 1995 Oct;63(1):65-76.

PMID:
8577492
7.

Clinically significant drug-drug interactions involving opioid analgesics used for pain treatment in patients with cancer: a systematic review.

Kotlinska-Lemieszek A, Klepstad P, Haugen DF.

Drug Des Devel Ther. 2015 Sep 16;9:5255-67. doi: 10.2147/DDDT.S86983. eCollection 2015. Review.

8.

Polypharmacy and chronic pain: harm exposure is not all about the opioids.

Giummarra MJ, Gibson SJ, Allen AR, Pichler AS, Arnold CA.

Pain Med. 2015 Mar;16(3):472-9. doi: 10.1111/pme.12586. Epub 2014 Oct 3.

PMID:
25280054
9.

Polypharmacy in the terminal stage of cancer.

Kierner KA, Weixler D, Masel EK, Gartner V, Watzke HH.

Support Care Cancer. 2016 May;24(5):2067-2074. doi: 10.1007/s00520-015-3007-z. Epub 2015 Nov 5.

PMID:
26542274
10.

The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the control of pain in advanced cancer. A systematic review of the literature.

Nabal M, Librada S, Redondo MJ, Pigni A, Brunelli C, Caraceni A.

Palliat Med. 2012 Jun;26(4):305-12. doi: 10.1177/0269216311428528. Epub 2011 Nov 29. Review.

PMID:
22126843
11.

Pain and pain treatments in European palliative care units. A cross sectional survey from the European Association for Palliative Care Research Network.

Klepstad P, Kaasa S, Cherny N, Hanks G, de Conno F; Research Steering Committee of the EAPC.

Palliat Med. 2005 Sep;19(6):477-84.

PMID:
16218160
12.

Opioid and adjuvant analgesics: compared and contrasted.

Khan MI, Walsh D, Brito-Dellan N.

Am J Hosp Palliat Care. 2011 Aug;28(5):378-83. doi: 10.1177/1049909111410298. Epub 2011 May 26. Review.

PMID:
21622486
13.

Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.

Doan J, Zakrzewski-Jakubiak H, Roy J, Turgeon J, Tannenbaum C.

Ann Pharmacother. 2013 Mar;47(3):324-32. doi: 10.1345/aph.1R621. Epub 2013 Mar 12.

PMID:
23482734
14.

Complexity of pain management among patients with nociceptive or neuropathic neck, back, or osteoarthritis diagnoses.

Kozma CM, Provenzano DA, Slaton TL, Patel AA, Benson CJ.

J Manag Care Spec Pharm. 2014 May;20(5):455-66b.

15.

Nonopioid drugs in the treatment of cancer pain.

Vardy J, Agar M.

J Clin Oncol. 2014 Jun 1;32(16):1677-90. doi: 10.1200/JCO.2013.52.8356. Epub 2014 May 5. Review.

PMID:
24799483
16.

Communication about opioid versus nonopioid analgesics in the emergency department.

McCarthy DM, Cameron KA, Courtney DM, Adams JG, Engel KG.

J Opioid Manag. 2015 May-Jun;11(3):229-36. doi: 10.5055/jom.2015.0271.

PMID:
25985807
17.

Use of strong opioids in advanced cancer pain: a randomized trial.

Marinangeli F, Ciccozzi A, Leonardis M, Aloisio L, Mazzei A, Paladini A, Porzio G, Marchetti P, Varrassi G.

J Pain Symptom Manage. 2004 May;27(5):409-16.

PMID:
15120769
18.
19.

Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions.

van Leeuwen RW, Jansman FG, van den Bemt PM, de Man F, Piran F, Vincenten I, Jager A, Rijneveld AW, Brugma JD, Mathijssen RH, van Gelder T.

Ann Oncol. 2015 May;26(5):992-7. doi: 10.1093/annonc/mdv029. Epub 2015 Jan 26.

PMID:
25628444
20.

Best practices to reduce the risk of drug-drug interactions: opportunities for managed care.

Fanciullo GJ, Washington T.

Am J Manag Care. 2011 Sep;17 Suppl 11:S299-304.

Supplemental Content

Support Center